运动瘤学试验中的传播规划 - - 对试验方案的系统审查
Emily Smyth1,2, Lydia Politi3, Emer Guinan1,2
1Discipline of Physiotherapy, Trinity College Dublin, Dublin, Ireland.
概括
运动瘤学试验中的传播规划往往缺乏,这阻碍了将研究转化为实践. 改善试验结果的分享方式对于癌症幸存者康复至关重要.
科学领域:
- 运动瘤学运动瘤学
- 传播和实施科学 传播和实施科学
- 临床试验设计 临床试验设计
背景情况:
- 对癌症幸存者的运动康复研究与其实际应用之间存在很大的差距.
- 传播和实施研究策略对于弥合这一差距至关重要,通过促进基于证据的干预措施.
- 有效地传播研究成果对于采用基于证据的实践至关重要.
研究的目的:
- 系统地审查运动瘤学试验协议,以遵守关于传播计划的SPIRIT 2013检查清单 (31a,31b,31c项目).
- 评估试验协议如何处理沟通结果,作者身份和数据/协议共享的计划.
- 确定在多大程度上将传播策略纳入运动瘤学试验的设计.
主要方法:
- 按照PRISMA指南进行了系统审查.
- 在多个数据库中进行了搜索,包括EMBASE,MEDLINE,CINAHL,Web of Science,Google Scholar和Cochrane中央审判注册表.
- 数据提取和标题/摘要的选是双重进行的.
主要成果:
- 在包括试验协议的86个中,36.1%缺乏任何报告的传播计划.
- 参与者 (22.1%),医疗保健专业人员 (50%) 和公众 (29.2%) 报告了沟通结果的计划.
- 关于作者资格 (3.5%) 和数据/协议共享 (32.6%用于数据集,1.2%用于协议/代码) 的报告特别低. 同行评审期刊 (47.67%) 和会议 (44.2%) 是最常见的传播方法.
结论:
- 运动瘤学试验协议显示,对SPIRIT 2013传播规划指南的遵守程度较低.
- 需要在运动瘤学研究中更加重视全面的传播规划.
- 加强传播规划对于促进运动瘤学研究结果在临床实践中的实施至关重要.
相关概念视频
Clinical Trials
6.6K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
6.6K
Cancer Survival Analysis
334
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
334
Hazard Ratio
96
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
For example, in a clinical trial...
96
Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
124
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
124


